COO

SELL

The Cooper Companies, Inc.

Healthcare · Rank #330 · Analyzed Apr 20, 2026

$70.06

Current Price

$66.33

Intrinsic Value

+31.9%

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score2/5.0

Framework RatingSELL

Price vs Intrinsic ValueUndervalued by 31.9%

Fair Value Range

Low$14.34

Base (IV)$66.33

High$92.44

Entry Points

Conservative$14.34

Moderate$40.33

Aggressive$66.33

Quality & Moat Breakdown

Return on Equity4.9% → 0/1.0

Debt LevelD/E 33 → 0.5/1.0

Revenue QualityGrowth 9.4%, margin Δ-12.9% +recovery → 1.0/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins9.7% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.